tiprankstipranks
Sonoma Pharmaceuticals (SNOA)
NASDAQ:SNOA

Sonoma Pharmaceuticals (SNOA) Financial Statements

245 Followers

Sonoma Pharmaceuticals Financial Overview

Sonoma Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.722; its P/E ratio is -0.51; Sonoma Pharmaceuticals is scheduled to report earnings on August 14, 2024, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 3.44M$ 3.14M$ 2.73M$ 3.43M$ 3.01M
Gross Profit$ 1.09M$ 1.46M$ 990.00K$ 1.20M$ 864.00K
EBIT$ -1.36M$ -844.00K$ -1.30M$ -1.45M$ -1.45M
EBITDA$ -1.32M$ -799.00K$ -1.25M$ -1.41M$ -1.42M
Net Income Common Stockholders$ -1.07M$ -866.00K$ -1.48M$ -1.42M$ -1.31M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.13M$ 2.41M$ 2.14M$ 3.54M$ 3.82M
Total Assets$ 14.74M$ 14.62M$ 13.63M$ 15.89M$ 16.23M
Total Debt$ 608.00K$ 385.00K$ 522.00K$ 655.00K$ 849.00K
Net Debt$ -2.52M$ -2.02M$ -1.61M$ -2.89M$ -2.97M
Total Liabilities$ 8.60M$ 7.93M$ 7.96M$ 8.65M$ 8.25M
Stockholders Equity$ 6.14M$ 6.69M$ 5.67M$ 7.24M$ 7.98M
Cash Flow-
Free Cash Flow$ 155.00K$ -1.10M$ -1.23M$ -232.00K$ -2.63M
Operating Cash Flow$ 152.00K$ -1.10M$ -1.23M$ -215.00K$ -2.44M
Investing Cash Flow$ 18.00K$ -1.00K$ -2.00K$ -17.00K$ -82.00K
Financing Cash Flow$ 622.00K$ 1.32M$ -129.00K$ -135.00K$ 3.37M
Currency in USD

Sonoma Pharmaceuticals Earnings and Revenue History

Sonoma Pharmaceuticals Debt to Assets

Sonoma Pharmaceuticals Cash Flow

Sonoma Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis